Literature DB >> 11733194

Rapid PCR-mediated synthesis of competitor molecules for accurate quantification of beta(2) GABA(A) receptor subunit mRNA.

J Vela1, J Vitorica, D Ruano.   

Abstract

We describe a fast and easy method for the synthesis of competitor molecules based on non-specific conditions of PCR. RT-competitive PCR is a sensitive technique that allows quantification of very low quantities of mRNA molecules in small tissue samples. This technique is based on the competition established between the native and standard templates for nucleotides, primers or other factors during PCR. Thus, the most critical parameter is the use of good internal standards to generate a standard curve from which the amount of native sequences can be properly estimated. At the present time different types of internal standards and methods for their synthesis have been described. Normally, most of these methods are time-consuming and require the use of different sets of primers, different rounds of PCR or specific modifications, such as site-directed mutagenesis, that need subsequent analysis of the PCR products. Using our method, we obtained in a single round of PCR and with the same primer pair, competitor molecules that were successfully used in RT-competitive PCR experiments. The principal advantage of this method is high versatility and economy. Theoretically it is possible to synthesize a specific competitor molecule for each primer pair used. Finally, using this method we have been able to quantify the increase in the expression of the beta(2) GABA(A) receptor subunit mRNA that occurs during rat hippocampus development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733194     DOI: 10.1016/s1385-299x(01)00109-x

Source DB:  PubMed          Journal:  Brain Res Brain Res Protoc        ISSN: 1385-299X


  1 in total

1.  Identification of microRNA profiles in salivary adenoid cystic carcinoma cells during metastatic progression.

Authors:  Wei Chen; Xiaoge Zhao; Zhen Dong; Gang Cao; Senlin Zhang
Journal:  Oncol Lett       Date:  2014-03-14       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.